Andrew Gaballa

Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond

M. Desai, Andrew Gaballa, Shada Jadam, 2024, Expert opinion on pharmacotherapy.

Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center.

M. Desai, M. Thamilarasan, Susan Ospina, 2024, Progress in cardiovascular diseases.

Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk Score

M. Desai, M. Thamilarasan, Susan Ospina, 2024, JACC: Advances.